chr19-7645248-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006949.4(STXBP2):​c.1298C>T​(p.Ala433Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,582,430 control chromosomes in the GnomAD database, including 129 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A433A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0087 ( 4 hom., cov: 34)
Exomes 𝑓: 0.011 ( 125 hom. )

Consequence

STXBP2
NM_006949.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.06

Publications

11 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003764242).
BP6
Variant 19-7645248-C-T is Benign according to our data. Variant chr19-7645248-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 194525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00866 (1319/152360) while in subpopulation AMR AF = 0.0152 (232/15306). AF 95% confidence interval is 0.0136. There are 4 homozygotes in GnomAd4. There are 608 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.1298C>T p.Ala433Val missense_variant Exon 15 of 19 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.1298C>T p.Ala433Val missense_variant Exon 15 of 19 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*1401C>T non_coding_transcript_exon_variant Exon 17 of 20 ENSP00000513686.1 A0A8V8TM65
ENSG00000268400ENST00000698368.1 linkn.*1401C>T 3_prime_UTR_variant Exon 17 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.00866
AC:
1318
AN:
152242
Hom.:
4
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00207
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0152
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.00329
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0128
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.00826
AC:
1662
AN:
201122
AF XY:
0.00839
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00956
Gnomad ASJ exome
AF:
0.00372
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00207
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0130
GnomAD4 exome
AF:
0.0113
AC:
16143
AN:
1430070
Hom.:
125
Cov.:
34
AF XY:
0.0113
AC XY:
8008
AN XY:
708292
show subpopulations
African (AFR)
AF:
0.00165
AC:
54
AN:
32804
American (AMR)
AF:
0.00988
AC:
402
AN:
40708
Ashkenazi Jewish (ASJ)
AF:
0.00407
AC:
104
AN:
25522
East Asian (EAS)
AF:
0.0000262
AC:
1
AN:
38180
South Asian (SAS)
AF:
0.00620
AC:
509
AN:
82054
European-Finnish (FIN)
AF:
0.00325
AC:
165
AN:
50750
Middle Eastern (MID)
AF:
0.0232
AC:
133
AN:
5724
European-Non Finnish (NFE)
AF:
0.0129
AC:
14168
AN:
1095198
Other (OTH)
AF:
0.0103
AC:
607
AN:
59130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
916
1833
2749
3666
4582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00866
AC:
1319
AN:
152360
Hom.:
4
Cov.:
34
AF XY:
0.00816
AC XY:
608
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41586
American (AMR)
AF:
0.0152
AC:
232
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4832
European-Finnish (FIN)
AF:
0.00329
AC:
35
AN:
10632
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0128
AC:
873
AN:
68022
Other (OTH)
AF:
0.0151
AC:
32
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
73
146
218
291
364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
36
Bravo
AF:
0.00876
TwinsUK
AF:
0.0121
AC:
45
ALSPAC
AF:
0.0114
AC:
44
ESP6500AA
AF:
0.00137
AC:
6
ESP6500EA
AF:
0.0121
AC:
104
ExAC
AF:
0.00621
AC:
747
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
May 05, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 14, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1.6% of total chromosomes in ExAC, 2.7% (44/1612) of Latino chromosomes -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STXBP2: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autoinflammatory syndrome Benign:1
Apr 04, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
22
DANN
Benign
0.91
DEOGEN2
Benign
0.15
.;T;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.37
N
LIST_S2
Uncertain
0.88
D;D;D
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.86
.;L;.
PhyloP100
1.1
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.31
T;T;T
Sift4G
Benign
0.31
T;T;T
Polyphen
0.037, 0.030
.;B;B
Vest4
0.22
MVP
0.64
MPC
0.24
ClinPred
0.0019
T
GERP RS
3.0
Varity_R
0.13
gMVP
0.37
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141309384; hg19: chr19-7710134; COSMIC: COSV99066080; COSMIC: COSV99066080; API